Filing Details

Accession Number:
0000921895-20-002310
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-24 09:12:32
Reporting Period:
2020-08-20
Accepted Time:
2020-08-24 09:12:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497504 Plx Pharma Inc. PLXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1389177 M Rita O'connor 9 Fishers Lane
Suite E
Sparta NJ 07871
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-20 2,300 $3.77 2,300 No 4 P Direct
Common Stock Acquisiton 2020-08-21 4,050 $3.97 6,350 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.74 to $3.80, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.
  2. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.85 to $4.10, inclusive. The Reporting Person undertakes to provide the Securities and Exchange Commission, upon request, further information regarding the number of shares purchased at each separate price such shares were purchased.